BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18094293)

  • 1. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis.
    Hanna RF; Kased N; Kwan SW; Gamst AC; Santosa AC; Hassanein T; Sirlin CB
    AJR Am J Roentgenol; 2008 Jan; 190(1):47-57. PubMed ID: 18094293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-contrast MRI in patients with cirrhosis.
    Guiu B; Loffroy R; Cercueil JP
    AJR Am J Roentgenol; 2008 Aug; 191(2):W78. PubMed ID: 18647893
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.
    Bhartia B; Ward J; Guthrie JA; Robinson PJ
    AJR Am J Roentgenol; 2003 Mar; 180(3):577-84. PubMed ID: 12591657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
    Nishie A; Tajima T; Ishigami K; Ushijima Y; Okamoto D; Hirakawa M; Nishihara Y; Taketomi A; Hatakenaka M; Irie H; Yoshimitsu K; Honda H
    J Magn Reson Imaging; 2010 Feb; 31(2):373-82. PubMed ID: 20099351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
    Coulam CH; Chan FP; Li KC
    AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
    Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ
    Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.
    Chung J; Yu JS; Kim DJ; Chung JJ; Kim JH; Kim KW
    Magn Reson Imaging; 2011 Nov; 29(9):1235-43. PubMed ID: 21907517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective audit to determine the diagnostic accuracy of Primovist-enhanced MRI in the detection of hepatocellular carcinoma in cirrhosis with explant histopathology correlation.
    Baird AJ; Amos GJ; Saad NF; Benson MD
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):314-20. PubMed ID: 23721140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
    Frericks BB; Loddenkemper C; Huppertz A; Valdeig S; Stroux A; Seja M; Wolf KJ; Albrecht T
    AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.
    Lauenstein TC; Salman K; Morreira R; Heffron T; Spivey JR; Martinez E; Sharma P; Martin DR
    AJR Am J Roentgenol; 2007 Sep; 189(3):663-70. PubMed ID: 17715115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.